Study S001900

A Multicentre, Prospective, Randomized, Open-label, Blinded Endpoint, Pilot Clinical Trial Evaluating Subcutaneous Semaglutide in Patients With Acute Ischaemic Stroke Due to Anterior Circulation Large Vessel Occlusion Treated With Endovascular Thrombectomy

ClinicalTrials.gov record

Registration

Registration: NCT07511543
Acronym: LEAST
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: SINGLE
Status: NOT_YET_RECRUITING
Enrollment: 100
Start: 2026-10-31
Primary completion: 2028-10-31
Lead sponsor: Population Health Research Institute
Conditions: Ischemic Stroke
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Feasibility - Recruitment [From site activation until the end of recruitment (approximately 24 months)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.